All Stories

  1. Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells
  2. Possible roles of transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases.
  3. Curcumin (Diferulolylmethane) Reduces Transglutaminase 2 Overexpression Induced by Retinoic Acid in Human Nervous Cell Lines
  4. Possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases
  5. Meet Our Editorial Board Member Dr. Vittorio Gentile
  6. Possible Role of the Transglutaminase Activity in Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
  7. Possible pathophysiological roles of transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases
  8. Transglutaminases and neurodegeneration
  9. Transglutaminases and neurodegeneration
  10. Transglutaminases and neurodegeneration
  11. Transglutaminase Inhibition as a Possible Therapeutical Approach to Protect Cells from Death in Neurodegenerative Diseases
  12. Pathophysiological Roles of Transglutaminase - Catalyzed Reactions in the Pathogenesis of Human Diseases
  13. Physiopathological Roles of Human Transglutaminase 2
  14. Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases
  15. Possible Role of the Transglutaminases in the Pathogenesis of Alzheimer's Disease and Other Neurodegenerative Diseases
  16. Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases
  17. Role of the Transglutaminase Enzymes in the Nervous System and their Possible Involvement in Neurodegenerative Diseases
  18. Transglutaminase covalently incorporates amines into human immunodeficiency virus envelope glycoprotein GP120 in vitro
  19. Transglutaminase-catalyzed modifications of SV-IV, a major protein secreted from the rat seminal vesicle epithelium
  20. Transglutaminase-Catalyzed Post-Translational Modifications of Proteins in the Nervous System and their Possible Involvement in Neurodegenerative Diseases
  21. Pathogenesis of Inclusion Bodies in (CAG)n/Qn-Expansion Diseases with Special Reference to the Role of Tissue Transglutaminase and to Selective Vulnerability
  22. Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders
  23. Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic
  24. Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: celiac disease
  25. Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases: Minireview article
  26. Transglutaminases - Possible Drug Targets in Human Diseases
  27. Abnormal Accumulation of tTGase Products in Muscle and Erythrocytes of Chorea-Acanthocytosis Patients
  28. Tissue transglutaminase and coeliac disease pathogenesis: potential molecular mechanisms for other human diseases
  29. Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)n/Qn-expansion diseases?
  30. Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases
  31. Changes in Tissue Transglutaminase Activity and Expression during Retinoic Acid-Induced Growth Arrest and Apoptosis in Primary Cultures of Human Epithelial Prostate Cells1
  32. TISSUE TRANSGLUTAMINASE EXPRESSION IN QUAIL EPIPHYSEAL CHONDROCYTES
  33. Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells
  34. Tissue Transglutaminase-Catalyzed Formation of High-Molecular-Weight Aggregatesin VitroIs Favored with Long Polyglutamine Domains: A Possible Mechanism Contributing to CAG-Triplet Diseases
  35. Lack of ‘tissue’ transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLlpr/lpr mice
  36. tTGase/Gαh protein expression inhibits adenylate cyclase activity in Balb-C 3T3 fibroblasts membranes
  37. Cell-biomaterial interactions: role of transglutaminase enzyme
  38. The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression
  39. Localization of the Human Prostate Transglutaminase (Type IV) Gene (TGM4) to Chromosome 3p21.33-p22 by Fluorescence in Situ Hybridization
  40. Isolation and Characterization of the Human Tissue Transglutaminase Gene Promoter
  41. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.
  42. The Human Tissue Transglutaminase Gene Maps on Chromosome 20q12 by in Situ Fluorescence Hybridization
  43. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion
  44. Cereal dietary proteins with sites for cross-linking by transglutaminase
  45. Spermine binding to subsynaptosomal fractions of rat brain cortex
  46. B-lipotropin 61–76 and 61–91 fragments act as transglutaminase substrates in vitro
  47. Implication of Transglutaminase in Mitogen-Induced Human Lymphocyte Blast Transformation
  48. ARE SOLUBLE AND/OR MEMBRANE-BOUND TRANSGLUTAMINASE ACTIVITIES INVOLVED IN INTESTINAL METABOLISM OF GLIADINS?
  49. Factors modulating immunocompatibility of spermatozoa: role of transglutaminase and SV-IV, one of the major proteins secreted from the rat seminal vesicle epithelium
  50. Transglutaminase-mediated modifications of the rat sperm surface in vitro
  51. Cerebral Polyamine Metabolism: Inhibition of Spermidine Biosynthesis by Dicyclohexylamine